ACADIA Pharmaceuticals Inc. Company Profile
3611 Valley Centre Drive
San Diego CA 92130
858-558-2871
www.acadia-pharm.com
Industry: Biotechnology
Sector: Healthcare

Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinsons disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzheimers disease psychosis. It also has clinical-stage programs for glaucoma and, in collaboration with Allergan, Inc., for chronic pain. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.